Immune Design Corp. 4
4 · Immune Design Corp. · Filed Jul 10, 2017
Insider Transaction Report
Form 4
COLEMAN LEWIS W
Director
Transactions
- Purchase
Common Stock
2017-07-06$9.39/sh+4,000$37,550→ 4,000 total(indirect: By Trust) - Purchase
Common Stock
2017-07-07$9.15/sh+4,000$36,600→ 8,000 total(indirect: By Trust)
Holdings
- 40,000
Common Stock
- 3,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.35 to $9.45 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- [F2]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.10 to $9.20 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.